Addiction News and Research

RSS

COVID-19 lockdown did not cause a mass surge in dispensing of opioids, study finds

While some feared that New Yorkers would re-fill prescriptions to stockpile opioid medications in the early weeks of the COVID-19 lockdown much in the way people hoarded toilet paper, in fact, New York State opioid prescriptions declined in the period around the March 20, 2020 "PAUSE" order, according to new research.

28 Nov 2022

Government introduces a Vaccine Taskforce style approach to tackle public health challenges in the UK

NHS patients are set to benefit from cutting-edge new treatments and technologies as the government introduces a Vaccine Taskforce style approach to tackling some of the biggest public health challenges facing the UK.

27 Nov 2022

Trickle of covid relief funds helps fill gaps in rural kids’ mental health services

The Mary Hill Youth and Family Center's building has long been at a crossroads overlooking this rural Appalachian city, but its purpose has evolved.

23 Nov 2022

Treating long covid is rife with guesswork

Medical equipment is still strewn around the house of Rick Lucas, 62, nearly two years after he came home from the hospital. He picks up a spirometer, a device that measures lung capacity, and takes a deep breath — though not as deep as he'd like.

22 Nov 2022

Schools, sheriffs, and syringes: State plans vary for spending $26B in opioid settlement funds

With more than 200 Americans still dying of drug overdoses each day, states are beginning the high-stakes task of deciding how to spend billions of dollars in settlement funds from opioid manufacturers and distributors.

22 Nov 2022

Protection afforded by SARS-CoV-2 infection against reinfection when Omicron BA.5 was the dominating subvariant in Scania county, Sweden

Researchers from Sweden conducted a cohort study to evaluate the protection granted by previous SARS-CoV-2 Omicron subvariant infections against reinfections among individuals vaccinated between June and August 2022.

17 Nov 2022

Augmented drug preferentially eliminates cancer cells but does not harm healthy cells

Johns Hopkins Medicine researchers have revamped an anti-cancer drug to better target cancer cells and leave healthy tissues unharmed. Scientists have dubbed this type of targeted approach a "prodrug" - a medicine designed to release its payload in a particular area of the body and in no other areas.

17 Nov 2022

ADHD drug associated with lowest risk of amphetamine-related hospitalizations and death

The ADHD medication lisdexamfetamine was associated with the lowest risk of hospitalization and death in people with amphetamine addiction, when medications generally used among persons with substance use disorders were compared.

16 Nov 2022

The player-coaches of addiction recovery work without boundaries

Sarah Wright stops by her peer support specialist's hotel room-turned-office in this Denver suburb several times a day.

16 Nov 2022

The brain's claustrum behaves more like a high-speed internet router, research finds

Tucked underneath the brain's outer, wrinkly cortex is a deeply mysterious area, known as the claustrum. This region has long been known to exchange signals with much of the cortex, which is responsible for higher reasoning and complex thought.

14 Nov 2022

New fentanyl vaccine could prevent deadly opioid from entering the brain

A research team led by the University of Houston has developed a vaccine targeting the dangerous synthetic opioid fentanyl that could block its ability to enter the brain, thus eliminating the drug's "high."

14 Nov 2022

Sick profit: Investigating private equity’s stealthy takeover of health care across cities and specialties

Two-year-old Zion Gastelum died just days after dentists performed root canals and put crowns on six baby teeth at a clinic affiliated with a private equity firm.

14 Nov 2022

New intervention helps patients with addiction to better manage their health

An intervention that teaches patients in addiction treatment how to better connect with their primary care medical team on both mental and physical health concerns resulted in long-term benefits over 5 years, including more primary care use and fewer substance-related emergency department visits, Kaiser Permanente researchers have found.

10 Nov 2022

Highly processed foods have addictive potential just as tobacco

Can highly processed foods be addictive? It’s a question that researchers have debated for years as unhealthy diets are often fueled by foods loaded with refined carbohydrates and added fats.

9 Nov 2022

Updated CDC guidelines for prescribing opioids

The United States Centers CDC updated their clinical practice guidelines for opioid prescription in pain management.

8 Nov 2022

New insight into how childhood traumas affect health outcomes

The social environments we grow up in are critical when determining our wellbeing and health later in life. Most Americans (67%) report experiencing at least one traumatic event in childhood, and a new study shows that these experiences have significant impacts on our health risks as adults.

8 Nov 2022

Rheumatoid arthritis patients taking opioids have twice the risk of venous thromboembolism

New research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual meeting, found that adult RA patients starting opioids had twice the risk of venous thromboembolism (VTE) compared to patients starting nonsteroidal anti-inflammatory drugs (NSAIDs).

8 Nov 2022

Addiction News and Research

COVID-19 lockdown did not cause a mass surge in dispensing of opioids, study finds

Government introduces a Vaccine Taskforce style approach to tackle public health challenges in the UK

Trickle of covid relief funds helps fill gaps in rural kids’ mental health services

Treating long covid is rife with guesswork

Schools, sheriffs, and syringes: State plans vary for spending $26B in opioid settlement funds

Protection afforded by SARS-CoV-2 infection against reinfection when Omicron BA.5 was the dominating subvariant in Scania county, Sweden

Augmented drug preferentially eliminates cancer cells but does not harm healthy cells

ADHD drug associated with lowest risk of amphetamine-related hospitalizations and death

The player-coaches of addiction recovery work without boundaries

The brain's claustrum behaves more like a high-speed internet router, research finds

New fentanyl vaccine could prevent deadly opioid from entering the brain

Sick profit: Investigating private equity’s stealthy takeover of health care across cities and specialties

New intervention helps patients with addiction to better manage their health

Highly processed foods have addictive potential just as tobacco

Updated CDC guidelines for prescribing opioids

New insight into how childhood traumas affect health outcomes

Rheumatoid arthritis patients taking opioids have twice the risk of venous thromboembolism

Experts analyze the intensity of use and addiction of e-cigarettes

UQ spin-off company to develop precision painkillers for treating debilitating conditions

Parental discord linked to children's genetic risk for alcohol problems

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News